The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin.
Meijer
C
C
Department of Internal Medicine, University Hospital, Groningen, The Netherlands.
Mulder
N H
NH
de Vries
E G
EG
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002945:Cisplatin / Q000493:pharmacokinetics* / Q000494:pharmacology; D004260:DNA Repair; D004317:Doxorubicin / Q000493:pharmacokinetics* / Q000494:pharmacology; D004351:Drug Resistance; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008658:Inactivation, Metabolic; D008562:Membrane Glycoproteins / Q000378:metabolism; D008668:Metallothionein / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D008562:Membrane Glycoproteins; D004317:Doxorubicin; D008668:Metallothionein; D005978:Glutathione; D002945:Cisplatin